Dian Diagnostics Group Co.,Ltd.

XSEC:300244 Stock Report

Market Cap: CN¥8.1b

Dian Diagnostics GroupLtd Balance Sheet Health

Financial Health criteria checks 5/6

Dian Diagnostics GroupLtd has a total shareholder equity of CN¥9.5B and total debt of CN¥3.8B, which brings its debt-to-equity ratio to 39.9%. Its total assets and total liabilities are CN¥17.1B and CN¥7.6B respectively. Dian Diagnostics GroupLtd's EBIT is CN¥406.9M making its interest coverage ratio 2.4. It has cash and short-term investments of CN¥1.7B.

Key information

39.9%

Debt to equity ratio

CN¥3.78b

Debt

Interest coverage ratio2.4x
CashCN¥1.73b
EquityCN¥9.48b
Total liabilitiesCN¥7.60b
Total assetsCN¥17.08b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300244's short term assets (CN¥12.8B) exceed its short term liabilities (CN¥4.9B).

Long Term Liabilities: 300244's short term assets (CN¥12.8B) exceed its long term liabilities (CN¥2.7B).


Debt to Equity History and Analysis

Debt Level: 300244's net debt to equity ratio (21.7%) is considered satisfactory.

Reducing Debt: 300244's debt to equity ratio has reduced from 63.2% to 39.9% over the past 5 years.

Debt Coverage: 300244's debt is well covered by operating cash flow (42.6%).

Interest Coverage: 300244's interest payments on its debt are not well covered by EBIT (2.4x coverage).


Balance Sheet


Discover healthy companies